Story thread · 2 reports / 2 sources
Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat
investors.com · 4d · first report
Biotech leader Kiniksa stock is poised to hit a fresh buy point after shares soared 25% in response to better-than-expected sales numbers. The post Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat appeared first on Investor's Business Daily .
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.